Tail suspension test to evaluate the antidepressant activity of experimental drugs

  • Muhammad Aslam Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi 75600, Pakistan.
Keywords: Antidepressant, Tail suspension test
DOI: 10.3329/bjp.v11i2.26517

References

Aslam M, Sultana N. Vitis vinifera juice ameliorates depression-like behavior in mice by modulating biogenic amine neurotransmitters. Bangladesh J Pharmacol. 2015; 10: 753-58.

Crowley J, Blendy J, Lucki I. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl). 2005; 183: 257-64.

Cryan J, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005; 29: 571-625.

Lad H, Liu L, Payá-Cano J, Fernandes C, Schalkwyk L. Quantitative traits for the tail suspension test: Automation, optimization, and BXD RI mapping. Mamm Genome. 2007; 18: 482-91.

Porsolt R, Anton G, Blavet N, Jalfre M. Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978; 47: 379-91.

Porsolt R, Bertin A, Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977; 229: 327-36.

Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl). 1985; 85: 367-70.

Thierry B, Steru L, Simon P, Porsolt R. The tail suspension test: Ethical considerations. Psychopharmacology (Berl). 1986; 90: 284-85.

Published
2016-03-13

Apply citation style format of Bangladesh Journal of Pharmacology

Section
Visual Experiment
Financial Support
Self-funded
Conflict of Interest
Authors declare no conflict of interest